Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Langland, an award-winning healthcare advertising agency, has launched "Speak Out, But Speak Smart" - an online communication guide for clinical trial participants. Developed in collaboration with CISCRP, a non-profit clinical research education organisation, the website encourages clinical trial participation discussions, while showing how sharing certain information can have unforseen consequences, for example psychosomatic side effects resulting from the knowledge of another participant's adverse event.
With the rise of the ePatient, the need for such a resource has never been greater. These digital-savy patients routinely use the internet not only to gather information about their condition, but also to disseminate their own experiences via blogs, forums and social media - a trend that presents both challenges and opportunities for our industry. Sharing study-related clinic visit experiences, for instance, can dispel misconceptions surrounding clinical research. But relaying any apparent health benefits to a fellow participant could spark a 'placebo effect' in that person.
Hosted on the CISCRP website, "Speak Out, But Speak Smart" brings to life the implications of such conversations through choose-your-own-ending animations. These allow the viewer to select how much information to divulge in different situations and explore the consequences of their choice.
"We are always looking for new and creative ways to educate patients and to encourage them to be informed partners in the research process," said Ken Getz, CISCRP Founder. "Speak Out, But Speak Smart is an entertaining and unique approach conveying how each individual's actions impact a research study."
"Patient communications via social media presents challenges for the healthcare industry," says Emma-Kate Yates, Langland's Group Account Director. "We're delighted to be part of an initiative that tackles issues head on with an aim to futher empower patients via an interactive experience complementing the environment they already occupy online."
To see "Speak Out, But Speak Smart" in action, visit http://www.ciscrp.org/patient/primer or access it via the informational videos section of CISCRP's website.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our IT / Internet / E-mail category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
CISCRP, Langland and. "Langland collaboration with CISCRP to show participants how their words can impact a clinical trial." Medical News Today. MediLexicon, Intl., 31 Oct. 2013. Web.
11 Dec. 2013. <http://www.medicalnewstoday.com/releases/268142>
CISCRP, L. (2013, October 31). "Langland collaboration with CISCRP to show participants how their words can impact a clinical trial." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/268142.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.